Status: current, Defined. Date: 31-Oct 2016. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3109321000168112 | Tripacel (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 10 microgram + diphtheria toxoid 30 international units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3109331000168110 | Tripacel injection, 0.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Tripacel injection, 5 x 0.5 mL vials | has TPUU | True | Tripacel injection, 0.5 mL vial | Inferred relationship | Some | 1 |
Tripacel injection, 5 x 0.5 mL vials | has TPUU | True | Tripacel injection, 0.5 mL vial | Inferred relationship | Some | 1 |
Tripacel injection, 0.5 mL vial | has TPUU | True | Tripacel injection, 0.5 mL vial | Inferred relationship | Some | 1 |
Tripacel injection, 0.5 mL vial | has TPUU | True | Tripacel injection, 0.5 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set